Because the gut is closely connected to other systems, these benefits may extend beyond digestion
Most clinical and research GHK-Cu protocols sit at 0.52 mg per day subcutaneously, and many patients do not inject every day - 23 injections per week is common for skin and maintenance goals
The act requires drugs to demonstrate safety and efficacy through an approved regulatory pathway before human use
IGF1-LR3, thanks to its long half-life, is highly effective in counteracting myostatin and appears to work by activating a muscle protein called MyoD [1], [2]
I got over that by injecting more frequently
In research settings, it is used as a model compound in studies involving peptide structure, signalling pathways, and controlled experimental systems